PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Clinical trials for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA trials appear
Sign up with your email to follow new studies for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug TURALIO takes on tough childhood cancers
Disease control Recruiting nowThis study is testing a drug called TURALIO (pexidartinib) in people aged 3 to 35 whose cancer has come back or not responded to standard treatments. The cancers include certain leukemias, solid tumors, and tumors linked to neurofibromatosis type 1. The goal is to find the safest…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:35 UTC
-
New hope for young leukemia patients: CART cell therapy trial launches
Disease control Recruiting nowThis early-phase trial tests whether a new type of CART cell therapy is safe and possible for children, teens, and young adults with leukemia that has come back or not responded to standard treatments. The study uses two different CART products based on the patient's specific leu…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE1 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated May 17, 2026 02:26 UTC
-
New combo therapy aims to boost leukemia remission with fewer side effects
Disease control Recruiting nowThis study tests a new approach for adults newly diagnosed with a specific type of leukemia (Ph-negative B-cell ALL) who cannot tolerate strong chemotherapy. It combines low-dose chemo with targeted immune drugs to try to wipe out cancer cells more safely. The goal is to achieve …
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 15, 2026 12:02 UTC
-
Engineered immune cells take on relapsed blood cancers in early trial
Disease control Recruiting nowThis early-phase study tests a personalized cell therapy called CART123 for adults with certain blood cancers (like acute myeloid leukemia) that have not responded to standard treatments. Each patient's own immune cells are modified in a lab to target and attack cancer cells. The…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated May 15, 2026 11:57 UTC